Silver Book Fact

Prescription eye drops could delay or prevent half of glaucoma cases in African Americans.

Higginbotham E, Gordon M, Beiser J, Drake M, et al. The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals. Archives of Ophthalmology. 2004; 122(6): 813-20. https://pubmed.ncbi.nlm.nih.gov/15197055/

Reference

Title
The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals
Publication
Archives of Ophthalmology
Publication Date
2004
Authors
Higginbotham E, Gordon M, Beiser J, Drake M, et al.
Volume & Issue
Volume 122, Issue 6
Pages
813-20
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.  
  • Because the resource use and direct cost of glaucoma treatment and management increases as the disease severity worsens– from an average $623 per early-stage patient to $2,511 per late-stage patient–…  
  • The ACCORD Eye Study found that combination lipid therapy with a fibrate and statin (compared with statin treatment alone) reduced progression of diabetic retinopathy in type 2 diabetics by around…  
  • Nearly 50% of diabetic retinopathy patients who received ranibizumab–an anti-VEGF drug–experienced substantial visual improvement after a year of injections  
  • Women taking vitamins B6 and B12 and folic acid–as compared to women not taking these supplements–were found to have a 34% lower risk of age-related macular degeneration (AMD) and a…